We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

707 hedge funds and large institutions have $17.7B invested in Charles River Laboratories in 2021 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 245 increasing their positions, 264 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $105M | Put options by funds: $57.7M

66% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 64

5% more funds holding

Funds holding: 676 → 707 (+31)

0.56% more ownership

Funds ownership: 92.91% → 93.47% (+0.56%)

7% less repeat investments, than reductions

Existing positions increased: 245 | Existing positions reduced: 264

8% less capital invested

Capital invested by funds: $19.3B → $17.7B (-$1.58B)

25% less funds holding in top 10

Funds holding in top 10: 20 → 15 (-5)

Holders
707
Holders Change
+31
Holders Change %
+4.59%
% of All Funds
10.88%
Holding in Top 10
15
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-25%
% of All Funds
0.23%
New
106
Increased
245
Reduced
264
Closed
64
Calls
$105M
Puts
$57.7M
Net Calls
+$47.4M
Net Calls Change
+$15.9M

Top Buyers

1
ClearBridge Investments
ClearBridge Investments
New York
+$210M
2
MCM
Melvin Capital Management
New York
+$112M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$82.6M
4
Marshall Wace
Marshall Wace
United Kingdom
+$59.2M
5
William Blair Investment Management
William Blair Investment Management
Illinois
+$51.9M

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$90.1M
2
Victory Capital Management
Victory Capital Management
Texas
-$72.1M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$66.6M
4
CIM
Confluence Investment Management
Missouri
-$51.8M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
-$45.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACB
51
Aristotle Capital Boston
Massachusetts
$66.2M -$18.2M -46,963 -21%
BNP Paribas Asset Management
52
BNP Paribas Asset Management
France
$65.4M +$5.34M +13,755 +9%
RP
53
Riverbridge Partners
Minnesota
$64.4M +$2.16M +5,553 +3%
ACM
54
American Capital Management
New York
$64.2M – – –
MBI
55
Montrusco Bolton Investments
Quebec, Canada
$62.1M +$10.2M +26,294 +19%
SBH
56
Segall Bryant & Hamill
Illinois
$61.7M -$1.64M -4,224 -3%
JP Morgan Chase
57
JP Morgan Chase
New York
$58.8M -$29.2M -75,036 -32%
UBS AM
58
UBS AM
Illinois
$53.8M +$1.49M +3,839 +3%
PCA
59
Personal Capital Advisors
California
$53.4M -$238K -612 -0.4%
Envestnet Asset Management
60
Envestnet Asset Management
Illinois
$53M +$5.04M +12,972 +10%
PPA
61
Parametric Portfolio Associates
Washington
$52.5M -$699K -1,798 -1%
Sumitomo Mitsui Trust Group
62
Sumitomo Mitsui Trust Group
Japan
$51.7M -$1.83M -4,714 -3%
SO
63
STRS Ohio
Ohio
$51.4M +$50.8M +130,820 +2,391%
CS
64
Candriam SCA
Luxembourg
$49.1M -$35.1M -90,296 -41%
Amundi
65
Amundi
France
$49M -$20M -51,448 -27%
EVM
66
Eaton Vance Management
Massachusetts
$46.2M -$6.69M -17,216 -12%
Goldman Sachs
67
Goldman Sachs
New York
$46.2M -$264K -680 -0.6%
SCM
68
Snyder Capital Management
California
$46M -$5.78M -14,873 -11%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$44.7M -$66.6M -171,535 -59%
Lord, Abbett & Co
70
Lord, Abbett & Co
New Jersey
$42M -$3.71M -9,555 -8%
California Public Employees Retirement System
71
California Public Employees Retirement System
California
$40.9M -$1.68M -4,313 -4%
CIBC Private Wealth Group
72
CIBC Private Wealth Group
Georgia
$38M +$699K +1,800 +2%
SEI Investments
73
SEI Investments
Pennsylvania
$35.4M -$1.12M -2,874 -3%
IHL
74
Investment House LLC
California
$34.5M -$358K -921 -1%
Stifel Financial
75
Stifel Financial
Missouri
$33.8M +$1.48M +3,804 +4%
1 2
3
4 5

CRL Hedge Fund Activity: Q4 2021 in Review

707 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2021, worth a combined $17.7B — down 8.2% from $19.3B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new CRL positions and 64 closed out — a net gain of 42 holders — while 245 added to existing stakes and 264 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $210M. The largest seller was Ameriprise, cutting an estimated $90.1M.

  • 707 institutional investors held Charles River Laboratories (CRL) as of Q4 2021, up from 676 in Q3 2021.
  • Funds reported $17.7B of Charles River Laboratories stock for Q4 2021, down 8.2% quarter-over-quarter.
  • 106 funds opened new Charles River Laboratories positions in Q4 2021 and 64 closed out, a net change of +42 holders.
  • The largest Charles River Laboratories buyer in Q4 2021 was ClearBridge Investments, an estimated $210M added.
  • The largest Charles River Laboratories seller in Q4 2021 was Ameriprise, an estimated $90.1M sold.

Based on aggregated 13F filings for Q4 2021.